Malignant intertrigo: A subset of toxic erythema of chemotherapy requiring recognition
Publication
, Journal Article
Smith, SM; Milam, PB; Fabbro, SK; Gru, AA; Kaffenberger, BH
Published in: JAAD Case Reports
November 2016
Duke Scholars
Published In
JAAD Case Reports
DOI
ISSN
2352-5126
Publication Date
November 2016
Volume
2
Issue
6
Start / End Page
476 / 481
Publisher
Elsevier BV
Related Subject Headings
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Smith, S. M., Milam, P. B., Fabbro, S. K., Gru, A. A., & Kaffenberger, B. H. (2016). Malignant intertrigo: A subset of toxic erythema of chemotherapy requiring recognition. JAAD Case Reports, 2(6), 476–481. https://doi.org/10.1016/j.jdcr.2016.08.016
Smith, Sabrina M., Philip B. Milam, Stephanie K. Fabbro, Alejandro A. Gru, and Benjamin H. Kaffenberger. “Malignant intertrigo: A subset of toxic erythema of chemotherapy requiring recognition.” JAAD Case Reports 2, no. 6 (November 2016): 476–81. https://doi.org/10.1016/j.jdcr.2016.08.016.
Smith SM, Milam PB, Fabbro SK, Gru AA, Kaffenberger BH. Malignant intertrigo: A subset of toxic erythema of chemotherapy requiring recognition. JAAD Case Reports. 2016 Nov;2(6):476–81.
Smith, Sabrina M., et al. “Malignant intertrigo: A subset of toxic erythema of chemotherapy requiring recognition.” JAAD Case Reports, vol. 2, no. 6, Elsevier BV, Nov. 2016, pp. 476–81. Crossref, doi:10.1016/j.jdcr.2016.08.016.
Smith SM, Milam PB, Fabbro SK, Gru AA, Kaffenberger BH. Malignant intertrigo: A subset of toxic erythema of chemotherapy requiring recognition. JAAD Case Reports. Elsevier BV; 2016 Nov;2(6):476–481.
Published In
JAAD Case Reports
DOI
ISSN
2352-5126
Publication Date
November 2016
Volume
2
Issue
6
Start / End Page
476 / 481
Publisher
Elsevier BV
Related Subject Headings
- 3202 Clinical sciences